Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether the combination of Temozolomide and Cisplatinum is effective in the treatment of malignant glial tumours of children and adolescents
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
NCT04166409 · Low Grade Astrocytoma, Low Grade Glioma, and more
NCT05804227 · Gliomas
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT06883214 · Glioma
NCT07450872 · Cancer, Glioma, and more
Institut Gustave-Roussy
Villejuif
Bristol Royal Hospital for Children
Bristol
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions